Ogochukwu M Ezeoke, G. Brooks, M. Postow, S. Baxi, L. Diamond
{"title":"Abstract C26: Associations Between race/ethnicity and enrollment in cancer research protocols","authors":"Ogochukwu M Ezeoke, G. Brooks, M. Postow, S. Baxi, L. Diamond","doi":"10.1158/1538-7755.DISP17-C26","DOIUrl":null,"url":null,"abstract":"Background: There is evidence of racial and ethnic disparities in clinical trial participation in oncology, but the studies reporting disparities tend to be small and specific to certain cancers. We aimed to use the experience of a large cancer center to investigate diverse participation in oncology research. Methods: We performed a retrospective cross-sectional analysis of all adult patients seen at Memorial Sloan Kettering Cancer Center (MSK) from 2005-2015. We examined if enrollment, defined as consent and registration to a research study, varied by race/ethnicity, a variable derived from the combination of self-reported values at MSK, gender, age, cancer type, and preferred language. Cancer type was determined by site and histology and designated as either common or rare, based on NCI criteria. Language preference was dichotomized to English and non-English. Descriptive and chi-square analyses examined bivariate associations between race/ethnicity and other characteristics, and research protocol enrollment. Due to large numbers of participants, associations were also assessed for clinical importance using standardized, chi-square residuals. Results: A total of 233,599 patients were available for analysis. 93,276 (39.9%) were enrolled in a research protocol. The mean + SD age of the enrolled observations was 57.7+13.7 and for those not enrolled, was 58.9+14.6 (Mann-Whitney U Test, p Conclusion: Patients who reported “other” race/ethnicity, whose preferred language was English, or who had common cancer diagnoses were more likely to be enrolled into a research protocol. Differences in enrollment on research protocols due to the additional race/ethnicity categories or gender were minimal. Further research is needed to understand the impact of these findings on diversity in oncology research protocols and to design interventions to reduce disparities in oncology trial enrollment. Citation Format: Ogochukwu Marietta Ezeoke, Gary Brooks, Michael A. Postow, Shrujal Baxi, Lisa Diamond. Associations Between race/ethnicity and enrollment in cancer research protocols [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr C26.","PeriodicalId":254061,"journal":{"name":"Behavioral and Social Science","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behavioral and Social Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7755.DISP17-C26","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: There is evidence of racial and ethnic disparities in clinical trial participation in oncology, but the studies reporting disparities tend to be small and specific to certain cancers. We aimed to use the experience of a large cancer center to investigate diverse participation in oncology research. Methods: We performed a retrospective cross-sectional analysis of all adult patients seen at Memorial Sloan Kettering Cancer Center (MSK) from 2005-2015. We examined if enrollment, defined as consent and registration to a research study, varied by race/ethnicity, a variable derived from the combination of self-reported values at MSK, gender, age, cancer type, and preferred language. Cancer type was determined by site and histology and designated as either common or rare, based on NCI criteria. Language preference was dichotomized to English and non-English. Descriptive and chi-square analyses examined bivariate associations between race/ethnicity and other characteristics, and research protocol enrollment. Due to large numbers of participants, associations were also assessed for clinical importance using standardized, chi-square residuals. Results: A total of 233,599 patients were available for analysis. 93,276 (39.9%) were enrolled in a research protocol. The mean + SD age of the enrolled observations was 57.7+13.7 and for those not enrolled, was 58.9+14.6 (Mann-Whitney U Test, p Conclusion: Patients who reported “other” race/ethnicity, whose preferred language was English, or who had common cancer diagnoses were more likely to be enrolled into a research protocol. Differences in enrollment on research protocols due to the additional race/ethnicity categories or gender were minimal. Further research is needed to understand the impact of these findings on diversity in oncology research protocols and to design interventions to reduce disparities in oncology trial enrollment. Citation Format: Ogochukwu Marietta Ezeoke, Gary Brooks, Michael A. Postow, Shrujal Baxi, Lisa Diamond. Associations Between race/ethnicity and enrollment in cancer research protocols [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr C26.
背景:有证据表明,在肿瘤学临床试验参与方面存在种族和民族差异,但研究报告的差异往往很小,并且仅限于某些癌症。我们的目标是利用大型癌症中心的经验来调查肿瘤研究中的不同参与。方法:我们对2005-2015年在纪念斯隆-凯特琳癌症中心(MSK)就诊的所有成年患者进行了回顾性横断面分析。我们检查了入组(定义为同意和注册研究)是否因种族/民族而异,种族/民族是由MSK自我报告值、性别、年龄、癌症类型和首选语言组合而成的变量。癌症类型由部位和组织学决定,并根据NCI标准划分为常见或罕见。语言偏好分为英语和非英语。描述性和卡方分析检查了种族/民族与其他特征和研究方案入组之间的双变量关联。由于参与者人数众多,还使用标准化的卡方残差评估了关联的临床重要性。结果:共有233,599例患者可用于分析。93,276例(39.9%)纳入研究方案。入组观察的平均+ SD年龄为57.7+13.7,未入组观察的平均+ SD年龄为58.9+14.6 (Mann-Whitney U Test, p)。结论:报告“其他”种族/民族、首选语言为英语或患有常见癌症诊断的患者更有可能被纳入研究方案。由于额外的种族/民族类别或性别,研究方案的入组差异很小。需要进一步的研究来了解这些发现对肿瘤研究方案多样性的影响,并设计干预措施以减少肿瘤试验入组的差异。引文格式:Ogochukwu Marietta Ezeoke, Gary Brooks, Michael A. Postow, Shrujal Baxi, Lisa Diamond。种族/民族与癌症研究方案登记之间的关系[摘要]。见:第十届AACR会议论文集:种族/少数民族和医疗服务不足人群的癌症健康差异科学;2017年9月25-28日;亚特兰大,乔治亚州。费城(PA): AACR;癌症流行病学杂志,2018;27(7增刊):摘要nr C26。